We are live on ! Find out more
VKTX icon

Viking Therapeutics
VKTX

144 hedge funds and large institutions have $280M invested in Viking Therapeutics in 2019 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 46 increasing their positions, 42 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

122% more call options, than puts

Call options by funds: $17.3M | Put options by funds: $7.82M

10% more repeat investments, than reductions

Existing positions increased: 46 | Existing positions reduced: 42

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

6.22% less ownership

Funds ownership: 62.59% → 56.37% (-6.2%)

8% less funds holding

Funds holding: 156 → 144 (-12)

25% less capital invested

Capital invested by funds: $374M → $280M (-$94.2M)

44% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 25

Holders
144
Holders Change
-12
Holders Change %
-7.69%
% of All Funds
3.16%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
14
Increased
46
Reduced
42
Closed
25
Calls
$17.3M
Puts
$7.82M
Net Calls
+$9.51M
Net Calls Change
+$2.31M

Top Buyers

Rank Fund Capital Flow
1
ACH
ArrowMark Colorado Holdings
Colorado
+$9.51M
2
AG
Artal Group
Luxembourg
+$1.86M
3
SG Americas Securities
SG Americas Securities
New York
+$1.67M
4
Millennium Management
Millennium Management
New York
+$1.26M
5
Victory Capital Management
Victory Capital Management
Texas
+$1.14M

Top Sellers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
-$22.8M
2
Vanguard Group
Vanguard Group
Pennsylvania
-$4.17M
3
NIP
Nicholas Investment Partners
California
-$4.02M
4
SSA
Schonfeld Strategic Advisors
New York
-$3.95M
5
OM
Opaleye Management
Massachusetts
-$3.32M
Name Holding Trade Value Shares
Change 		Change in
Stake
CS
76
Credit Suisse
Switzerland
$270K +$36.2K +4,869 +14%
Parallax Volatility Advisers
77
Parallax Volatility Advisers
California
$266K -$80.3K -10,809 -22%
Envestnet Asset Management
78
Envestnet Asset Management
Illinois
$263K -$3.55K -478 -1%
ECM
79
ExodusPoint Capital Management
New York
$245K +$133K +17,966 +102%
Barclays
80
Barclays
United Kingdom
$234K -$212K -28,509 -46%
BC
81
Brinker Capital
Pennsylvania
$225K +$18.9K +2,544 +8%
VEA
82
Virtus ETF Advisers
New York
$221K -$13.3K -1,790 -5%
Federated Hermes
83
Federated Hermes
Pennsylvania
$215K +$232K +31,261 New
MIM
84
MetLife Investment Management
New Jersey
$197K – – –
Ameriprise
85
Ameriprise
Minnesota
$191K +$36.9K +4,965 +22%
VOYA Investment Management
86
VOYA Investment Management
Georgia
$184K – – –
IGGA
87
Iron Gate Global Advisors
Utah
$178K – – –
TAM
88
Tocqueville Asset Management
New York
$174K -$70.4K -9,475 -27%
AGM
89
Alpine Global Management
New York
$172K – – –
AG
90
Advisor Group
Arizona
$166K +$14.6K +1,971 +9%
Jane Street
91
Jane Street
New York
$164K +$2.12K +286 +1%
Stifel Financial
92
Stifel Financial
Missouri
$162K -$2.45K -330 -1%
IWM
93
IHT Wealth Management
Illinois
$160K – – –
EMG
94
Ellington Management Group
Connecticut
$156K +$169K +22,700 New
State Board of Administration of Florida Retirement System
95
State Board of Administration of Florida Retirement System
Florida
$152K – – –
M&T Bank
96
M&T Bank
New York
$151K +$9.51K +1,280 +6%
JP Morgan Chase
97
JP Morgan Chase
New York
$147K +$26.8K +3,611 +20%
LPL Financial
98
LPL Financial
California
$147K +$31.1K +4,183 +24%
MLICM
99
Metropolitan Life Insurance Company (MetLife)
New York
$146K – – –
California Public Employees Retirement System
100
California Public Employees Retirement System
California
$134K -$5.88K -791 -4%
2 3
4
5 6

VKTX Hedge Fund Activity: Q3 2019 in Review

144 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Viking Therapeutics (VKTX) for Q3 2019, worth a combined $280M — down 25% from $374M a quarter earlier.

Sellers outnumbered buyers: 25 funds closed out of VKTX and 14 opened new positions — a net loss of 11 holders — while 42 trimmed existing stakes and 46 added.

The largest buyer was ArrowMark Colorado Holdings, adding an estimated $9.51M. The largest seller was State Street, cutting an estimated $22.8M.

  • 144 institutional investors held Viking Therapeutics (VKTX) as of Q3 2019, down from 156 in Q2 2019.
  • Funds reported $280M of Viking Therapeutics stock for Q3 2019, down 25% quarter-over-quarter.
  • 14 funds opened new Viking Therapeutics positions in Q3 2019 and 25 closed out, a net change of -11 holders.
  • The largest Viking Therapeutics buyer in Q3 2019 was ArrowMark Colorado Holdings, an estimated $9.51M added.
  • The largest Viking Therapeutics seller in Q3 2019 was State Street, an estimated $22.8M sold.

Based on aggregated 13F filings for Q3 2019.